The Pharmacokinetic Exposure to Fexofenadine is Volume‐Dependently Reduced in Healthy Subjects Following Oral Administration With Apple Juice

• Published in: Clinical and translational science Vol. 9; no. 4; pp. 201 - 206
• Main Authors: Luo, J, Imai, H, Ohyama, T, Hashimoto, S, Hasunuma, T, Inoue, Y, Kotegawa, T, Ohashi, K, Uemura, N
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01-08-2016; John Wiley and Sons Inc
• Subjects: Administration, Oral; Beverages; Blood & organ donations; Clinical trials; Drug dosages; Exposure; Female; Fexofenadine; Fruit juices; Healthy Volunteers; Humans; Laboratories; Male; Malus; Medical research; Oral administration; Pharmaceuticals; Pharmacokinetics; Studies; Terfenadine - administration & dosage; Terfenadine - analogs & derivatives; Terfenadine - blood; Terfenadine - pharmacokinetics; Japan
• ISSN: 1752-8054; 1752-8062
• DOI: 10.1111/cts.12400

Pharmacokinetic exposures to fexofenadine (FEX) are reduced by apple juice (AJ); however, the relationship between the AJ volume and the degree of AJ‐FEX interaction has not been understood. In this crossover study, 10 healthy subjects received single doses of FEX 60 mg with different volumes (150, 300, and 600 mL) of AJ or water (control). To identify an AJ volume lacking clinically meaningful interaction, we tested a hypothesis that the 90% confidence interval (CI) for geometric mean ratio (GMR) of FEX AUCAJ/AUCwater is contained within a biocomparability bound of 0.5–2.0, with at least one tested volume of AJ. GMR (90% CI) of AUCAJ 150mL/AUCwater, AUCAJ 300mL/AUCwater, and AUCAJ 600mL/AUCwater were 0.903 (0.752–1.085), 0.593 (0.494–0.712), and 0.385 (0.321–0.462), respectively. While a moderate to large AJ‐FEX interaction is caused by a larger volumes of AJ (e.g., 300 to 600 mL), the effect of a small volume (e.g., 150 mL) appears to be not meaningful.